Latest Stock Buy or Sell? Make More Informed Decisions!

This is a Turkish energy play who recent announced a major discovery. He does not own it as he wonders how long it may take to bring the discovery onto production.

This stock has been a source of frustration for many investors. Recent earnings guidance has disappointed the market. Their margins have been eroded and they hold a lot of debt. He thinks this is getting closer to an entry.

Not a small cap company today. Their last quarterly earnings got squeezed hard. He likes the management team and continues to hold it. He hopes management will be able to prove themselves over the next couple of quarters.

This has not done much for the past couple of years. They have a great balance sheet. They have signed a couple of contracts recently and have recently beat analyst earning expectations. He thinks this is a great take-over target and he has a large holding.

He has a large holding in this. Operationally the company has done well, but the multiple is not cheap. He will continue to hold.

He has not followed this on-line gaming company too closely. If you hold it, continue to as they seem to be able to defend their market position.

Despite the recent disappointing earnings, he continues to like holding it. A recent acquisition was quite sizable and he thinks this will allow earnings growth to continue. It may become a good take-over target and he likes the business model.

A hydro-vac company for excavation. It trades at 14.2 times earnings and there was very good earnings recently. Their dividend was increased by 18% recently. They have diversified into infrastructure and away from oil and gas. Yield 1.9%. (Analysts’ price target is $32.38 )

A bit of a contrarian pick given the high level of debt. He thinks they are starting to pay down $300-$500 million of debt. It is close to a ten year low and believes the market has pushed the price too low. Management feels comfortable and reports day rates are increasing. Yield 0%. (Analysts’ price target is $5.39 )

He recommended this back in December and it has done extremely well. The company produces health monitoring devices to remind people to take medication at home. They have 50,000 patients under contract and rolling out at 2000-3000 per month. Yield 0%. (Analysts’ price target is $3.00 )

(A Top Pick May 25/17 Up 48%). This is his second largest holding. They continue to grow their production per share. They have amassed some great highly productive wells. Their cash flow should continue to grow, perhaps over $1 per share. They have the second highest netbacks in the industry.

(A Top Pick May 25/17 Up 30%). It is very cheap and good value. They beat expectations on recent earnings and are reducing backlogs and the balance sheet looks great.

(A Top Pick May 25/17 Up 4%). On Monday this week a US company said it has put a bid out for the company. The price is rumoured at $9.70 Canadian. He is one of the largest shareholders in this company. The largest shareholder group is encouraging management to engage in the offer.